Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Angion Biomedica

Angion Biomedica
1998 FOUNDED
PRIVATE STATUS
21-30 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$20.8M LATEST DEAL AMOUNT
Description

Developer of biopharmaceutical drugs designed to treat renal diseases including acute kidney injury and chronic renal disease. The company's organ restoration drugs are developed using rational drug design to target the body's protective, reparative and regenerative system for therapeutic benefit, enabling patients to begin more quickly, resulting in a better medical outcome.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • 51 Charles Lindbergh Boulevard
  • Uniondale, NY 11553
  • United States

+1 (516) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Angion Biomedica’s full profile, request a free trial.

Angion Biomedica Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 17-Jul-2018 $20.8M 000.00 Completed Generating Revenue
2. Later Stage VC (Series A) 20-Feb-2015 00.000 00.000 000.00 Completed Startup
1. IPO 24-Oct-2014 Cancelled Startup
To view this company’s complete deal history including valuation and funding, request access »

Angion Biomedica Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000 00.000000 00 0000.00 0000.00 00 0000.00
To view this company’s complete Cap Table, request access »

Angion Biomedica Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Tricida Formerly VC-backed South San Francisco, CA 00 00000 00000000 00000
00000 000000000000 Formerly VC-backed Boston, MA 000 0000 000000&0 0000
00000000 Angel-Backed Culver City, CA 00000 000000000000 00000
000000000 Venture Capital-Backed Rockville, MD 000.00 0000000000 0 000.00
00000000000 Formerly VC-backed Raleigh, NC 00 000.00 0000000000.
To view this company’s complete list of competitors, request access »

Angion Biomedica Executive Team (5)

Name Title Board
Seat
Contact
Info
Jay Venkatesan MD Chief Executive Officer & President
Andrew Savadelis Chief Financial Officer
Itzhak Goldberg MD Founder, Chief Scientific Officer & Executive Chairman, Chairman of the Board and Secretary
Micheal Yamin Ph.D Vice President, Corporate Affairs & Director
Prakash Narayan Ph.D Vice President of Preclinical Research

Angion Biomedica Board Members (1)

Name Representing Role Since Contact
Info
Itzhak Goldberg MD Angion Biomedica Founder, Chief Scientific Officer & Executive Chairman, Chairman of the Board and Secretary 000 0000